Regenxbio Inc (RGNX)

Days of sales outstanding (DSO)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Receivables turnover		3.45	3.19	13.77	6.77	1.56
DSO	days	105.72	114.56	26.51	53.89	233.77

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.45
= 105.72

Regenxbio Inc's Days Sales Outstanding (DSO) measures the average number of days it takes for the company to collect revenue after making a sale. A lower DSO indicates faster payment collection and better liquidity management.

Analyzing the trend of DSO for Regenxbio Inc over the past five years reveals significant fluctuations. In 2019, the DSO was notably high at 395.20 days, indicating a prolonged collection period. This may have been due to issues with customer payment delays or inefficient credit and collection policies.

However, in 2021, there was a substantial improvement in DSO to 25.17 days, suggesting more efficient collections and potentially stricter credit policies. This sharp decrease is a positive sign of enhanced cash flow management and strong customer payment practices.

In the following years, there was an upward trend in DSO, with a notable increase to 100.27 days in 2023. This rise in DSO may raise concerns about the company's ability to collect payments promptly and efficiently. It could indicate challenges with accounts receivable management, potential credit risks, or changes in customer payment behavior.

Overall, a comprehensive analysis of Regenxbio Inc's DSO highlights the importance of closely monitoring and managing the collection of accounts receivable to maintain healthy liquidity and financial stability.